Skip to search formSkip to main contentSkip to account menu

Caspofungin acetate

The acetate salt of an antimycotic echinocandin lipopeptide, semisynthetically derived from a fermentation product of the fungus Glarea lozoyensis… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
We report a facile, one-step, aqueous surface bioconjugation approach for producing an antifungal surface coating that prevents… 
2010
2010
ABSTRACT According to the product insert for Cancidas (caspofungin acetate), the drug must not be diluted in solutions containing… 
Review
2008
Review
2008
Infections and adverse drug reactions both contribute substantially to mortality after allogeneic stem cell transplantation. It… 
2008
2008
PURPOSE The physical compatibility of i.v. caspofungin with other commonly used i.v. medications was tested. METHODS Two… 
2007
2007
A novel three-step synthesis of the highly functionalized antifungal agent CANCIDAS (caspofungin acetate, 2) is described… 
2006
2006
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
ObjectiveSystemic fungal infections have high mortality, and therapy is often toxic. Caspofungin acetate, a new antifungal agent… 
2003
2003
We present a patient with acute myeloid leukaemia who developed subcutaneously disseminated aspergillosis after allogeneic… 
Review
2001
Review
2001
The pharmacology, bioavailability and pharmacokinetics, clinical efficacy, and adverse effects of caspofungin acetate are…